Cargando…

Brain angiotensin II in dopaminergic imbalance-derived pathologies: neuroinflammation and vascular responses

Detalles Bibliográficos
Autores principales:	Occhieppo, Victoria Belén, Basmadjian, Osvaldo Martin, Bregonzio, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996039/ https://www.ncbi.nlm.nih.gov/pubmed/32985475 http://dx.doi.org/10.4103/1673-5374.293144

Ejemplares similares

Amphetamine Induces Oxidative Stress, Glial Activation and Transient Angiogenesis in Prefrontal Cortex via AT(1)-R
por: Basmadjian, Osvaldo M., et al.
Publicado: (2021)

Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D(2)- muscarinic acetylcholine M(1) receptor heteromer
por: Crans, René A. J., et al.
Publicado: (2020)

Pathologically Entangled: Brain Trauma-Evoked ROS Imbalance Disrupts Kir Channel Function in Distant Peripheral Vessels
por: Weir, Nick, et al.
Publicado: (2021)

Angiotensin II AT(1) Receptors Are Involved in Neuronal Activation Induced by Amphetamine in a Two-Injection Protocol
por: Paz, Maria Constanza, et al.
Publicado: (2013)

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2016)

Imbalance between angiotensin II and angiotensin-(1–7) in human coronary atherosclerosis
por: Li, Wenjing, et al.
Publicado: (2016)

Fear-Potentiated Behaviour Is Modulated by Central Amygdala Angiotensin II AT(1) Receptors Stimulation
por: Marinzalda, Maria de los Angeles, et al.
Publicado: (2014)

Advanced brain organoids for neuroinflammation disease modeling
por: Sabate-Soler, Sonia, et al.
Publicado: (2023)

Methylation reactions at dopaminergic nerve endings, serving as biological off-switches in managing dopaminergic functions
por: Charlton, Clivel G.
Publicado: (2014)

Gut-brain axis in traumatic brain injury: impact on neuroinflammation
por: Celorrio, Marta, et al.
Publicado: (2021)

Editorial: Targeting Neuroinflammation in Central Nervous System Disorders: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Pérez, Mariela Fernanda, et al.
Publicado: (2021)

Neuroinflammation and COVID-19
por: Vanderheiden, Abigail, et al.
Publicado: (2022)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Renin angiotensin system and gender differences in dopaminergic degeneration
por: Rodriguez-Perez, Ana I, et al.
Publicado: (2011)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2018)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
por: Mahajani, Sameehan, et al.
Publicado: (2020)

Drug- and cell-based therapies for targeting neuroinflammation in traumatic brain injury
por: Kaelber, Sussannah, et al.
Publicado: (2016)

Endocannabinoid control of neuroinflammation in traumatic brain injury by monoacylglycerol lipase in astrocytes
por: Chen, Chu
Publicado: (2022)

Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology
por: St. Paul, Amanda, et al.
Publicado: (2020)

Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018)

Targeting neuroinflammation after therapeutic hypothermia for perinatal hypoxic-ischemic brain injury
por: Zhou, Kelly Q., et al.
Publicado: (2022)

Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
por: Seltzer, S.
Publicado: (2020)

Brain renin-angiotensin system and dopaminergic cell vulnerability
por: Labandeira-García, Jose L., et al.
Publicado: (2014)

A new mechanism for protection of dopaminergic neurons mediated by astrocytes
por: Segura-Aguilar, Juan
Publicado: (2015)

Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons
por: Ou, Zhou, et al.
Publicado: (2016)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Aires, Inês Dinis, et al.
Publicado: (2021)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Application of flavonoids for the protection of nigral dopaminergic neurons from oxidative stress
por: Kim, Sang Ryong
Publicado: (2020)

Glial-derived transforming growth factor β1 (TGF-β1): a key factor in multiple sclerosis neuroinflammation
por: Guevara, Coram, et al.
Publicado: (2020)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
por: Wong, Martin C.S., et al.
Publicado: (2020)

Iron, the endolysosomal system and neuroinflammation: a matter of balance
por: Bórquez, Daniel A., et al.
Publicado: (2021)

Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice()
por: Cozzoli, Anna, et al.
Publicado: (2011)

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
por: Paul, Bindu D., et al.
Publicado: (2021)

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons
por: Kim, Sang Ryong
Publicado: (2014)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Neuroinflammation, Neuroautoimmunity, and the Co-Morbidities of Complex Regional Pain Syndrome
por: Cooper, Mark S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jjhiu1ejq3361eeqb9a1fn29p8